{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:38:31Z","timestamp":1768714711595,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ygyno.2005.08.053","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T08:44:45Z","timestamp":1130229885000},"page":"487-494","source":"Crossref","is-referenced-by-count":27,"title":["Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest"],"prefix":"10.1016","volume":"100","author":[{"given":"Victoria L.","family":"Bae-Jump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola A.","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young E.","family":"Whang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2005.08.053_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(98)80172-6","article-title":"Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling","volume":"10","author":"Abraham","year":"1998","journal-title":"Curr. Opin. Immunol."},{"issue":"56","key":"10.1016\/j.ygyno.2005.08.053_bib2","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1204091","article-title":"The rapamycin-sensitive signal transduction pathway as a target for cancer therapy","volume":"19","author":"Hidalgo","year":"2000","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ygyno.2005.08.053_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.cco.0000143964.74936.d1","article-title":"Targeting the molecular target of rapamycin (mTOR)","volume":"16","author":"Rowinsky","year":"2004","journal-title":"Curr. Opin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2005.08.053_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0955-0674(98)80150-6","article-title":"The mRNA 5\u2032 cap-binding protein eIF4E and control of cell growth","volume":"10","author":"Sonenberg","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2005.08.053_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00323-2","article-title":"The modular phosphorylation and activation of p70s6k","volume":"410","author":"Pullen","year":"1997","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.ygyno.2005.08.053_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/sj.bjc.6602162","article-title":"Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer","volume":"91","author":"Chan","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"5573","key":"10.1016\/j.ygyno.2005.08.053_bib7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.ygyno.2005.08.053_bib8","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1073\/pnas.211430998","article-title":"AKT plays a central role in tumorigenesis","volume":"98","author":"Testa","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"34","key":"10.1016\/j.ygyno.2005.08.053_bib9","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","article-title":"AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth","volume":"23","author":"Altomare","year":"2004","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.ygyno.2005.08.053_bib10","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"Campbell","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ygyno.2005.08.053_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/scbi.2000.0339","article-title":"Telomerase and human tumorigenesis","volume":"10","author":"Stewart","year":"2000","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.ygyno.2005.08.053_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MMBR.66.3.407-425.2002","article-title":"Human telomerase and its regulation","volume":"66","author":"Cong","year":"2002","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.ygyno.2005.08.053_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/gyno.1997.4921","article-title":"Telomerase activity in the female reproductive tract and neoplasms","volume":"68","author":"Yokoyama","year":"1998","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2005.08.053_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.1996.4523","article-title":"Telomerase activity in gynecologic tumors","volume":"64","author":"Zheng","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2005.08.053_bib15","first-page":"1558","article-title":"Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer","volume":"58","author":"Takakura","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2005.08.053_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0002-9440(10)65627-1","article-title":"Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer","volume":"153","author":"Nakano","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2005.08.053_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2004.01.036","article-title":"Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer","volume":"93","author":"Widschwendter","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2005.08.053_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1099>3.0.CO;2-7","article-title":"Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer","volume":"91","author":"Wisman","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2005.08.053_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<426::AID-IJC17>3.0.CO;2-1","article-title":"Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors","volume":"84","author":"Park","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2005.08.053_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<804::AID-IJC2>3.0.CO;2-B","article-title":"Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors","volume":"80","author":"Kyo","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2005.08.053_bib21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1200\/JCO.2003.09.065","article-title":"Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma","volume":"21","author":"Buttitta","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.ygyno.2005.08.053_bib22","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1038\/sj.onc.1207582","article-title":"Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines","volume":"23","author":"Kimura","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ygyno.2005.08.053_bib23","first-page":"452","article-title":"Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay","volume":"6","author":"Bieche","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.ygyno.2005.08.053_bib24","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1073\/pnas.171060098","article-title":"An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/\u2212 mice","volume":"98","author":"Podsypanina","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.ygyno.2005.08.053_bib25","first-page":"5027","article-title":"Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779","volume":"62","author":"Shi","year":"2002","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.ygyno.2005.08.053_bib26","first-page":"6141","article-title":"Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells","volume":"62","author":"Grunwald","year":"2002","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.ygyno.2005.08.053_bib27","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR","volume":"98","author":"Neshat","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.ygyno.2005.08.053_bib28","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/emboj\/16.12.3693","article-title":"Rapamycin suppresses 5\u2032 TOP mRNA translation through inhibition of p70s6k","volume":"16","author":"Jefferies","year":"1997","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.ygyno.2005.08.053_bib29","first-page":"789","article-title":"Rapamycin inhibits telomerase activity by decreasing the hTERT mRNA level in endometrial cancer cells","volume":"2","author":"Zhou","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.ygyno.2005.08.053_bib30","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1073\/pnas.93.12.6091","article-title":"Cell cycle-dependent modulation of telomerase activity in tumor cells","volume":"93","author":"Zhu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.ygyno.2005.08.053_bib31","doi-asserted-by":"crossref","first-page":"10687","DOI":"10.1073\/pnas.94.20.10687","article-title":"Lack of cell cycle regulation of telomerase activity in human cells","volume":"94","author":"Holt","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.ygyno.2005.08.053_bib32","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2005.08.053_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-291X(03)00343-7","article-title":"Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells","volume":"303","author":"Bruemmer","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.ygyno.2005.08.053_bib34","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"issue":"23","key":"10.1016\/j.ygyno.2005.08.053_bib35","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1074\/jbc.273.23.14424","article-title":"Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability","volume":"273","author":"Hashemolhosseini","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ygyno.2005.08.053_bib36","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0002-9440(10)64681-0","article-title":"Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas","volume":"158","author":"Kurose","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2005.08.053_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ygyno.2004.03.013","article-title":"Epigenetic and genetic alternation of PTEN in cervical neoplasm","volume":"93","author":"Cheung","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2005.08.053_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/erc.0.0080249","article-title":"mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer","volume":"8","author":"Yu","year":"2001","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805007298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805007298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T10:27:11Z","timestamp":1548066431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805007298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0090825805007298"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.08.053","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}